Bioxyne forecasts doubling of revenue amid ‘$100m gummy opportunity’ by Steve Jones September 26, 2024September 26, 2024 Bioxyne has forecast revenues will double to A$20 million in FY25 on the back of contracts […]
New compounding guidelines signal ‘willingness of regulator to enforce the rules’, pharmacists are warned by Steve Jones September 26, 2024September 26, 2024
Cultivator edges towards $500k in Birchal crowdfunding campaign by Steve Jones September 25, 2024September 26, 2024
Regulatory action ‘not pretty’ as doctors are told to ‘know your obligations’ by Steve Jones September 24, 2024September 24, 2024
Treat dependency, not sleep or pain, argues top specialist by Steve Jones September 19, 2024September 20, 2024
Brett Schwarz among senior departures from Cannatrek by Steve Jones September 19, 2024September 19, 2024
Montu named as customer behind ‘$28m’ gummy deal as Bioxyne resumes trading on ASX by Steve Jones September 18, 2024September 19, 2024
New compliance chief puts ‘high-volume, high-speed’ clinics on notice as efforts begin to clean up industry by Steve Jones September 18, 2024September 18, 2024
AHPRA issues string of advertising warning letters following complaints from the public by Martin Lane September 17, 2024September 18, 2024
Montu to offer Birchal investors up to $14m in share buy-back pay day by Steve Jones September 12, 2024September 12, 2024
